Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
20.59
+0.05 (0.24%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Genmab Market Cap
Genmab has a market cap or net worth of $12.78 billion as of April 25, 2025. Its market cap has decreased by -35.46% in one year.
Market Cap
12.78B
Enterprise Value
9.72B
1-Year Change
-35.46%
Ranking
Category
Stock Price
$20.59
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $12.78B, an increase of 2,939.59%. That is a compound annual growth rate of 30.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 13.59B | -1.57% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.03B |
| UnitedHealth Group | 379.82B |
| Johnson & Johnson | 369.19B |
| AbbVie | 328.41B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.53B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |